EligibleTrials

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

Recruiting · NCT07348237 · Interventional (participants receive a specific treatment) · Lead sponsor: Merck Sharp & Dohme LLC

View the official record on ClinicalTrials.gov →
Chronic kidney disease

Interventions studied

MK-2828

What this trial is about

The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.

Who can take part

Age range
24 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

3 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.